oligo primers
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), under the Dept Of Defense / DEPT OF THE NAVY, is issuing a Special Notice to procure customized primers and probes for molecular diagnosis of various viruses. These materials are essential for their existing RT real-time PCR assays. Responses are due by March 26, 2026.
Scope of Work
NAMRU SOUTH's Virology Department requires customized primers and probes for the molecular diagnosis of a wide range of viruses, including Dengue (four serotypes), Chikungunya, Zika, Mayaro, Hantavirus, Orthobunyavirus, Influenza (A-matrix gene and B, with subtypes H3, H1pdm/SwH1N1, H1 seasonal), and SARS-CoV-2. These will be used in RT real-time PCR assays on various sample types from febrile and respiratory surveillance protocols.
Key Requirements
Materials must be compatible with NAMRU SOUTH's validated TaqMan 7500/7500 Fast Real time PCR system and QuantStudio platforms. Using different materials would necessitate re-validation, causing significant delays. The required items, detailed in 'Book1.xlsx', include:
- DNA-1 Custom Oligonucleotide: 23 Bases, 2 Inosines, 1umol (5 EA)
- LNA-FB1-50sp Dual-labeled LNA Probe: 5' FAM/2 LNA Bases/3' MGB-EDQ, 50nmol (various quantities)
- DLO-FBN-1 5' FAM BHQnova Probe
- DLO-COB1-1 Dual-labeled Probe: 5' CAL Fluor® Orange 560/3' BHQ-1, 1 umol (5.0)
- DLO-Q6B2-1 Dual-labeled Probe: 5' Quasar 670/3' BHQ-2 1 µmol (2.0)
- DLO-Q7B2-1 Dual-labeled Probe: 5' Quasar 705/3' BHQ-2 1 µmol (2.0)
- LNA-FB1-50 Dual-labeled LNA Probe: 5' FAM/3' BHQ-1 50 nmol (4.0)
- DLO-FB1-1 Dual-labeled Probe: 5' FAM/3' BHQ-1 1 µmol (various quantities)
- MGB-FEDQ-60 Dual-labeled MGB Probe: 5' FAM/3' MGB-EDQ 1 µmol (2.0)
- PPC-1 Primer: Cartridge Purified (up to 30 bases each) 1 µmol (58.0)
- PP-2 Primer: Salt-Free (up to 30 bases each) 200 nmol (16.0)
- P1-2 Primer: Avg. 23 Bases, Salt-Free 200 nmol (370.0)
- Multiplex Primers & Probe: For Influenza A, Influenza B, SARS-CoV-2, and Human RNase P Extraction Control (2.0 EA each)
Contract & Timeline
- Type: Special Notice
- Set-Aside: None specified
- Response Due: March 26, 2026, 4:00 PM EST
- Published: March 12, 2026
- Place of Performance: Lima, Peru (delivery to Washington, DC)
Additional Notes
Shipment of primers is expected to occur as soon as the contract is awarded to NAMRU-SOUTH, 3230 Lima Place, Washington, DC 20521. Interested parties should contact Genaro Vasquez at genaro.m.vasquez.ln@health.mil or 0115116244128.